世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

脊椎医療機器と生物製剤の世界市場成長 2024-2030


Global Spinal Devices and Biologics Market Growth 2024-2030

世界の脊椎装置と生物製剤の市場規模は、2023年の100万米ドルから2030年には100万米ドルに成長すると予測され、2024年から2030年までの年平均成長率は%と予測されています。 LPインフォメーション株式会社(東... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
LP Information
LPインフォメーション
2024年5月24日 US$3,660
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
111 英語

日本語のページは自動翻訳を利用し作成しています。


 

サマリー

世界の脊椎装置と生物製剤の市場規模は、2023年の100万米ドルから2030年には100万米ドルに成長すると予測され、2024年から2030年までの年平均成長率は%と予測されています。
LPインフォメーション株式会社(東京都千代田区/代表取締役:劉克振、以下LPI)の最新調査レポート「脊椎治療器と生物製剤の産業予測」は、2023年の脊椎治療器と生物製剤の世界総売上高を過去の売上高から検証し、2024年から2030年までの脊椎治療器と生物製剤の予測売上高を地域別・市場分野別に包括的に分析しています。脊椎医療機器と生物製剤の売上高を地域別、市場分野別、サブセクター別に分類し、世界の脊椎医療機器と生物製剤産業の詳細な分析を百万米ドル単位で提供しています。
本インサイトレポートは、世界の脊椎装置および生物製剤の状況を包括的に分析し、製品区分、企業形成、収益、市場シェア、最新動向、M&A活動に関する主要動向を明らかにします。また本レポートでは、加速する世界の脊椎医療機器および生物製剤市場におけるこれらの企業の独自のポジションをより良く理解するために、脊椎医療機器および生物製剤のポートフォリオと能力、市場参入戦略、市場での地位、地理的な足跡に焦点を当てて、主要グローバル企業の戦略を分析しています。
この調査レポートは、脊椎医療機器と生物製剤の世界的な見通しを形成する主要な市場動向、促進要因、影響要因を評価し、タイプ別、用途別、地域別、市場規模別に予測を細分化して、新たな機会のポケットを浮き彫りにします。何百ものボトムアップの質的・量的市場インプットに基づいた透明性の高い手法により、この調査予測は世界の脊椎装置と生物製剤の現状と将来の軌道について非常にニュアンスのある見解を提供します。
脊椎装置と生物製剤の米国市場は、2023年の100万米ドルから2030年には100万米ドルに増加し、2024年から2030年までの年平均成長率は%と推定される。
脊椎デバイスと生物製剤の中国市場は、2023年の100万米ドルから2030年には100万米ドルに、2024年から2030年までの年平均成長率は%と推定される。
脊椎デバイスと生物製剤のヨーロッパ市場は、2023年の百万米ドルから2030年には百万米ドルに増加し、2024年から2030年までの年平均成長率は%と推定される。
脊椎装置と生物製剤の世界の主要企業は、Nuvasive、Orthofix International、Exactech、Wright Medical Group、Johnson & Johnsonなどである。収益面では、2023年には世界の大手2社がほぼ%のシェアを占めている。
本レポートでは、脊髄デバイスと生物製剤市場の包括的な概要、市場シェア、成長機会を、製品タイプ、用途、主要メーカー、主要地域、国別に紹介します。
タイプ別セグメント
脊椎固定
動作保持
非融合技術
骨折治療
その他
用途別セグメント
病院
外来手術センター
クリニック
その他
本レポートではまた、市場を地域別に分けています:
南北アメリカ
アメリカ
カナダ
メキシコ
ブラジル
APAC
中国
日本
韓国
東南アジア
インド
オーストラリア
ヨーロッパ
ドイツ
フランス
英国
イタリア
ロシア
中東・アフリカ
エジプト
南アフリカ
イスラエル
トルコ
GCC諸国
以下の企業は、一次専門家から収集した情報、および企業のカバレッジ、製品ポートフォリオ、市場浸透度の分析に基づいて選択されています。
ニューバシブ
オルソフィックス・インターナショナル
イグザクテック
ライト・メディカル・グループ
ジョンソン・エンド・ジョンソン
ジンマー・バイオメット
グローバス・メディカル
K2M
メドトロニック
アルファテック・ホールディングス
RTIサージカル
本レポートで扱う主な質問
世界の脊髄デバイスと生物製剤市場の10年見通しは?
世界および地域別で、脊髄デバイスと生物製剤市場の成長を促進する要因は何か?
市場別、地域別に最も急成長する技術は何か?
脊椎デバイスと生物製剤の市場機会は最終市場規模によってどのように異なるのか?
脊髄デバイスと生物製剤のタイプ別、用途別内訳は?


ページTOPに戻る


目次

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Spinal Devices and Biologics Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Spinal Devices and Biologics by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Spinal Devices and Biologics by Country/Region, 2019, 2023 & 2030
2.2 Spinal Devices and Biologics Segment by Type
2.2.1 Spinal Fusion & Fixation
2.2.2 Motion Preservation
2.2.3 Non-Fusion Technologies
2.2.4 Fracture Treatment
2.2.5 Others
2.3 Spinal Devices and Biologics Sales by Type
2.3.1 Global Spinal Devices and Biologics Sales Market Share by Type (2019-2024)
2.3.2 Global Spinal Devices and Biologics Revenue and Market Share by Type (2019-2024)
2.3.3 Global Spinal Devices and Biologics Sale Price by Type (2019-2024)
2.4 Spinal Devices and Biologics Segment by Application
2.4.1 Hospitals
2.4.2 Ambulatory Surgical Centers
2.4.3 Clinics
2.4.4 Others
2.5 Spinal Devices and Biologics Sales by Application
2.5.1 Global Spinal Devices and Biologics Sale Market Share by Application (2019-2024)
2.5.2 Global Spinal Devices and Biologics Revenue and Market Share by Application (2019-2024)
2.5.3 Global Spinal Devices and Biologics Sale Price by Application (2019-2024)
3 Global Spinal Devices and Biologics by Company
3.1 Global Spinal Devices and Biologics Breakdown Data by Company
3.1.1 Global Spinal Devices and Biologics Annual Sales by Company (2019-2024)
3.1.2 Global Spinal Devices and Biologics Sales Market Share by Company (2019-2024)
3.2 Global Spinal Devices and Biologics Annual Revenue by Company (2019-2024)
3.2.1 Global Spinal Devices and Biologics Revenue by Company (2019-2024)
3.2.2 Global Spinal Devices and Biologics Revenue Market Share by Company (2019-2024)
3.3 Global Spinal Devices and Biologics Sale Price by Company
3.4 Key Manufacturers Spinal Devices and Biologics Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Spinal Devices and Biologics Product Location Distribution
3.4.2 Players Spinal Devices and Biologics Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Spinal Devices and Biologics by Geographic Region
4.1 World Historic Spinal Devices and Biologics Market Size by Geographic Region (2019-2024)
4.1.1 Global Spinal Devices and Biologics Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Spinal Devices and Biologics Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Spinal Devices and Biologics Market Size by Country/Region (2019-2024)
4.2.1 Global Spinal Devices and Biologics Annual Sales by Country/Region (2019-2024)
4.2.2 Global Spinal Devices and Biologics Annual Revenue by Country/Region (2019-2024)
4.3 Americas Spinal Devices and Biologics Sales Growth
4.4 APAC Spinal Devices and Biologics Sales Growth
4.5 Europe Spinal Devices and Biologics Sales Growth
4.6 Middle East & Africa Spinal Devices and Biologics Sales Growth
5 Americas
5.1 Americas Spinal Devices and Biologics Sales by Country
5.1.1 Americas Spinal Devices and Biologics Sales by Country (2019-2024)
5.1.2 Americas Spinal Devices and Biologics Revenue by Country (2019-2024)
5.2 Americas Spinal Devices and Biologics Sales by Type
5.3 Americas Spinal Devices and Biologics Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Spinal Devices and Biologics Sales by Region
6.1.1 APAC Spinal Devices and Biologics Sales by Region (2019-2024)
6.1.2 APAC Spinal Devices and Biologics Revenue by Region (2019-2024)
6.2 APAC Spinal Devices and Biologics Sales by Type
6.3 APAC Spinal Devices and Biologics Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Spinal Devices and Biologics by Country
7.1.1 Europe Spinal Devices and Biologics Sales by Country (2019-2024)
7.1.2 Europe Spinal Devices and Biologics Revenue by Country (2019-2024)
7.2 Europe Spinal Devices and Biologics Sales by Type
7.3 Europe Spinal Devices and Biologics Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Spinal Devices and Biologics by Country
8.1.1 Middle East & Africa Spinal Devices and Biologics Sales by Country (2019-2024)
8.1.2 Middle East & Africa Spinal Devices and Biologics Revenue by Country (2019-2024)
8.2 Middle East & Africa Spinal Devices and Biologics Sales by Type
8.3 Middle East & Africa Spinal Devices and Biologics Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Spinal Devices and Biologics
10.3 Manufacturing Process Analysis of Spinal Devices and Biologics
10.4 Industry Chain Structure of Spinal Devices and Biologics
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Spinal Devices and Biologics Distributors
11.3 Spinal Devices and Biologics Customer
12 World Forecast Review for Spinal Devices and Biologics by Geographic Region
12.1 Global Spinal Devices and Biologics Market Size Forecast by Region
12.1.1 Global Spinal Devices and Biologics Forecast by Region (2025-2030)
12.1.2 Global Spinal Devices and Biologics Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Spinal Devices and Biologics Forecast by Type
12.7 Global Spinal Devices and Biologics Forecast by Application
13 Key Players Analysis
13.1 Nuvasive
13.1.1 Nuvasive Company Information
13.1.2 Nuvasive Spinal Devices and Biologics Product Portfolios and Specifications
13.1.3 Nuvasive Spinal Devices and Biologics Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Nuvasive Main Business Overview
13.1.5 Nuvasive Latest Developments
13.2 Orthofix International
13.2.1 Orthofix International Company Information
13.2.2 Orthofix International Spinal Devices and Biologics Product Portfolios and Specifications
13.2.3 Orthofix International Spinal Devices and Biologics Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Orthofix International Main Business Overview
13.2.5 Orthofix International Latest Developments
13.3 Exactech
13.3.1 Exactech Company Information
13.3.2 Exactech Spinal Devices and Biologics Product Portfolios and Specifications
13.3.3 Exactech Spinal Devices and Biologics Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Exactech Main Business Overview
13.3.5 Exactech Latest Developments
13.4 Wright Medical Group
13.4.1 Wright Medical Group Company Information
13.4.2 Wright Medical Group Spinal Devices and Biologics Product Portfolios and Specifications
13.4.3 Wright Medical Group Spinal Devices and Biologics Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Wright Medical Group Main Business Overview
13.4.5 Wright Medical Group Latest Developments
13.5 Johnson & Johnson
13.5.1 Johnson & Johnson Company Information
13.5.2 Johnson & Johnson Spinal Devices and Biologics Product Portfolios and Specifications
13.5.3 Johnson & Johnson Spinal Devices and Biologics Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Johnson & Johnson Main Business Overview
13.5.5 Johnson & Johnson Latest Developments
13.6 Zimmer Biomet
13.6.1 Zimmer Biomet Company Information
13.6.2 Zimmer Biomet Spinal Devices and Biologics Product Portfolios and Specifications
13.6.3 Zimmer Biomet Spinal Devices and Biologics Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Zimmer Biomet Main Business Overview
13.6.5 Zimmer Biomet Latest Developments
13.7 Globus Medical
13.7.1 Globus Medical Company Information
13.7.2 Globus Medical Spinal Devices and Biologics Product Portfolios and Specifications
13.7.3 Globus Medical Spinal Devices and Biologics Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Globus Medical Main Business Overview
13.7.5 Globus Medical Latest Developments
13.8 K2M
13.8.1 K2M Company Information
13.8.2 K2M Spinal Devices and Biologics Product Portfolios and Specifications
13.8.3 K2M Spinal Devices and Biologics Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 K2M Main Business Overview
13.8.5 K2M Latest Developments
13.9 Medtronic
13.9.1 Medtronic Company Information
13.9.2 Medtronic Spinal Devices and Biologics Product Portfolios and Specifications
13.9.3 Medtronic Spinal Devices and Biologics Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Medtronic Main Business Overview
13.9.5 Medtronic Latest Developments
13.10 Alphatec Holdings
13.10.1 Alphatec Holdings Company Information
13.10.2 Alphatec Holdings Spinal Devices and Biologics Product Portfolios and Specifications
13.10.3 Alphatec Holdings Spinal Devices and Biologics Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Alphatec Holdings Main Business Overview
13.10.5 Alphatec Holdings Latest Developments
13.11 RTI Surgical
13.11.1 RTI Surgical Company Information
13.11.2 RTI Surgical Spinal Devices and Biologics Product Portfolios and Specifications
13.11.3 RTI Surgical Spinal Devices and Biologics Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 RTI Surgical Main Business Overview
13.11.5 RTI Surgical Latest Developments
14 Research Findings and Conclusion

 

ページTOPに戻る


 

Summary

The global Spinal Devices and Biologics market size is projected to grow from US$ million in 2023 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Spinal Devices and Biologics Industry Forecast” looks at past sales and reviews total world Spinal Devices and Biologics sales in 2023, providing a comprehensive analysis by region and market sector of projected Spinal Devices and Biologics sales for 2024 through 2030. With Spinal Devices and Biologics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Spinal Devices and Biologics industry.
This Insight Report provides a comprehensive analysis of the global Spinal Devices and Biologics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Spinal Devices and Biologics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Spinal Devices and Biologics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Spinal Devices and Biologics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Spinal Devices and Biologics.
United States market for Spinal Devices and Biologics is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Spinal Devices and Biologics is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Spinal Devices and Biologics is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Spinal Devices and Biologics players cover Nuvasive, Orthofix International, Exactech, Wright Medical Group and Johnson & Johnson, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Spinal Devices and Biologics market by product type, application, key manufacturers and key regions and countries.
Segmentation by type
Spinal Fusion & Fixation
Motion Preservation
Non-Fusion Technologies
Fracture Treatment
Others
Segmentation by application
Hospitals
Ambulatory Surgical Centers
Clinics
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Nuvasive
Orthofix International
Exactech
Wright Medical Group
Johnson & Johnson
Zimmer Biomet
Globus Medical
K2M
Medtronic
Alphatec Holdings
RTI Surgical
Key Questions Addressed in this Report
What is the 10-year outlook for the global Spinal Devices and Biologics market?
What factors are driving Spinal Devices and Biologics market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Spinal Devices and Biologics market opportunities vary by end market size?
How does Spinal Devices and Biologics break out type, application?



ページTOPに戻る


Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Spinal Devices and Biologics Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Spinal Devices and Biologics by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Spinal Devices and Biologics by Country/Region, 2019, 2023 & 2030
2.2 Spinal Devices and Biologics Segment by Type
2.2.1 Spinal Fusion & Fixation
2.2.2 Motion Preservation
2.2.3 Non-Fusion Technologies
2.2.4 Fracture Treatment
2.2.5 Others
2.3 Spinal Devices and Biologics Sales by Type
2.3.1 Global Spinal Devices and Biologics Sales Market Share by Type (2019-2024)
2.3.2 Global Spinal Devices and Biologics Revenue and Market Share by Type (2019-2024)
2.3.3 Global Spinal Devices and Biologics Sale Price by Type (2019-2024)
2.4 Spinal Devices and Biologics Segment by Application
2.4.1 Hospitals
2.4.2 Ambulatory Surgical Centers
2.4.3 Clinics
2.4.4 Others
2.5 Spinal Devices and Biologics Sales by Application
2.5.1 Global Spinal Devices and Biologics Sale Market Share by Application (2019-2024)
2.5.2 Global Spinal Devices and Biologics Revenue and Market Share by Application (2019-2024)
2.5.3 Global Spinal Devices and Biologics Sale Price by Application (2019-2024)
3 Global Spinal Devices and Biologics by Company
3.1 Global Spinal Devices and Biologics Breakdown Data by Company
3.1.1 Global Spinal Devices and Biologics Annual Sales by Company (2019-2024)
3.1.2 Global Spinal Devices and Biologics Sales Market Share by Company (2019-2024)
3.2 Global Spinal Devices and Biologics Annual Revenue by Company (2019-2024)
3.2.1 Global Spinal Devices and Biologics Revenue by Company (2019-2024)
3.2.2 Global Spinal Devices and Biologics Revenue Market Share by Company (2019-2024)
3.3 Global Spinal Devices and Biologics Sale Price by Company
3.4 Key Manufacturers Spinal Devices and Biologics Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Spinal Devices and Biologics Product Location Distribution
3.4.2 Players Spinal Devices and Biologics Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Spinal Devices and Biologics by Geographic Region
4.1 World Historic Spinal Devices and Biologics Market Size by Geographic Region (2019-2024)
4.1.1 Global Spinal Devices and Biologics Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Spinal Devices and Biologics Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Spinal Devices and Biologics Market Size by Country/Region (2019-2024)
4.2.1 Global Spinal Devices and Biologics Annual Sales by Country/Region (2019-2024)
4.2.2 Global Spinal Devices and Biologics Annual Revenue by Country/Region (2019-2024)
4.3 Americas Spinal Devices and Biologics Sales Growth
4.4 APAC Spinal Devices and Biologics Sales Growth
4.5 Europe Spinal Devices and Biologics Sales Growth
4.6 Middle East & Africa Spinal Devices and Biologics Sales Growth
5 Americas
5.1 Americas Spinal Devices and Biologics Sales by Country
5.1.1 Americas Spinal Devices and Biologics Sales by Country (2019-2024)
5.1.2 Americas Spinal Devices and Biologics Revenue by Country (2019-2024)
5.2 Americas Spinal Devices and Biologics Sales by Type
5.3 Americas Spinal Devices and Biologics Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Spinal Devices and Biologics Sales by Region
6.1.1 APAC Spinal Devices and Biologics Sales by Region (2019-2024)
6.1.2 APAC Spinal Devices and Biologics Revenue by Region (2019-2024)
6.2 APAC Spinal Devices and Biologics Sales by Type
6.3 APAC Spinal Devices and Biologics Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Spinal Devices and Biologics by Country
7.1.1 Europe Spinal Devices and Biologics Sales by Country (2019-2024)
7.1.2 Europe Spinal Devices and Biologics Revenue by Country (2019-2024)
7.2 Europe Spinal Devices and Biologics Sales by Type
7.3 Europe Spinal Devices and Biologics Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Spinal Devices and Biologics by Country
8.1.1 Middle East & Africa Spinal Devices and Biologics Sales by Country (2019-2024)
8.1.2 Middle East & Africa Spinal Devices and Biologics Revenue by Country (2019-2024)
8.2 Middle East & Africa Spinal Devices and Biologics Sales by Type
8.3 Middle East & Africa Spinal Devices and Biologics Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Spinal Devices and Biologics
10.3 Manufacturing Process Analysis of Spinal Devices and Biologics
10.4 Industry Chain Structure of Spinal Devices and Biologics
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Spinal Devices and Biologics Distributors
11.3 Spinal Devices and Biologics Customer
12 World Forecast Review for Spinal Devices and Biologics by Geographic Region
12.1 Global Spinal Devices and Biologics Market Size Forecast by Region
12.1.1 Global Spinal Devices and Biologics Forecast by Region (2025-2030)
12.1.2 Global Spinal Devices and Biologics Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Spinal Devices and Biologics Forecast by Type
12.7 Global Spinal Devices and Biologics Forecast by Application
13 Key Players Analysis
13.1 Nuvasive
13.1.1 Nuvasive Company Information
13.1.2 Nuvasive Spinal Devices and Biologics Product Portfolios and Specifications
13.1.3 Nuvasive Spinal Devices and Biologics Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Nuvasive Main Business Overview
13.1.5 Nuvasive Latest Developments
13.2 Orthofix International
13.2.1 Orthofix International Company Information
13.2.2 Orthofix International Spinal Devices and Biologics Product Portfolios and Specifications
13.2.3 Orthofix International Spinal Devices and Biologics Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Orthofix International Main Business Overview
13.2.5 Orthofix International Latest Developments
13.3 Exactech
13.3.1 Exactech Company Information
13.3.2 Exactech Spinal Devices and Biologics Product Portfolios and Specifications
13.3.3 Exactech Spinal Devices and Biologics Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Exactech Main Business Overview
13.3.5 Exactech Latest Developments
13.4 Wright Medical Group
13.4.1 Wright Medical Group Company Information
13.4.2 Wright Medical Group Spinal Devices and Biologics Product Portfolios and Specifications
13.4.3 Wright Medical Group Spinal Devices and Biologics Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Wright Medical Group Main Business Overview
13.4.5 Wright Medical Group Latest Developments
13.5 Johnson & Johnson
13.5.1 Johnson & Johnson Company Information
13.5.2 Johnson & Johnson Spinal Devices and Biologics Product Portfolios and Specifications
13.5.3 Johnson & Johnson Spinal Devices and Biologics Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Johnson & Johnson Main Business Overview
13.5.5 Johnson & Johnson Latest Developments
13.6 Zimmer Biomet
13.6.1 Zimmer Biomet Company Information
13.6.2 Zimmer Biomet Spinal Devices and Biologics Product Portfolios and Specifications
13.6.3 Zimmer Biomet Spinal Devices and Biologics Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Zimmer Biomet Main Business Overview
13.6.5 Zimmer Biomet Latest Developments
13.7 Globus Medical
13.7.1 Globus Medical Company Information
13.7.2 Globus Medical Spinal Devices and Biologics Product Portfolios and Specifications
13.7.3 Globus Medical Spinal Devices and Biologics Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Globus Medical Main Business Overview
13.7.5 Globus Medical Latest Developments
13.8 K2M
13.8.1 K2M Company Information
13.8.2 K2M Spinal Devices and Biologics Product Portfolios and Specifications
13.8.3 K2M Spinal Devices and Biologics Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 K2M Main Business Overview
13.8.5 K2M Latest Developments
13.9 Medtronic
13.9.1 Medtronic Company Information
13.9.2 Medtronic Spinal Devices and Biologics Product Portfolios and Specifications
13.9.3 Medtronic Spinal Devices and Biologics Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Medtronic Main Business Overview
13.9.5 Medtronic Latest Developments
13.10 Alphatec Holdings
13.10.1 Alphatec Holdings Company Information
13.10.2 Alphatec Holdings Spinal Devices and Biologics Product Portfolios and Specifications
13.10.3 Alphatec Holdings Spinal Devices and Biologics Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Alphatec Holdings Main Business Overview
13.10.5 Alphatec Holdings Latest Developments
13.11 RTI Surgical
13.11.1 RTI Surgical Company Information
13.11.2 RTI Surgical Spinal Devices and Biologics Product Portfolios and Specifications
13.11.3 RTI Surgical Spinal Devices and Biologics Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 RTI Surgical Main Business Overview
13.11.5 RTI Surgical Latest Developments
14 Research Findings and Conclusion

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(医療)の最新刊レポート


よくあるご質問


LP Information社はどのような調査会社ですか?


LP Informationは通信、エネルギー、医薬をはじめとする広範な市場の調査とレポート出版を行っている調査会社です。 もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/12/24 10:26

158.45 円

165.22 円

201.28 円

ページTOPに戻る